Always Remember - Buy The Dip

Sentiment Analysis For SAGE

The news is currently generally neutral for SAGE.

Based on TextBlob analysis of Yahoo! Finance news summaries for SAGE on 2015-03-24.

Yahoo! Finance News for SAGE

SAGE Therapeutics Q4 Loss Widens - Quick Facts
SAGE Therapeutics Q4 Loss Widens - Quick Facts

Sage Therapeutics (SAGE) in Focus: Stock Falls 7.4% - Tale of the Tape
Sage Therapeutics, Inc. ( SAGE ) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in

Sector Update: Health Care Stocks Generally Higher Pre-Bell
Top Health care stocks JNJ +0.39% PFE +0.33% ABT +0.11% MRK +0.32% AMGN 0.67% Health care shares were generally higher in pre market trade Tuesday. In health care stocks news, Radius Health ( RDUS ) reported Q3 financial results

Sector Update: Health Care
Health care shares were generally higher in pre market trade Tuesday. In health care stocks news, Radius Health ( RDUS ) reported Q3 financial results Tuesday, with a net loss of $17.4 million, or $0.59 per share, narrowing from

5 Best Biotech Stocks to Buy Now
By Jeff Reeves, Editor of InvestorPlace.com Biotech stocks to buy arent exactly the most popular investments on Wall Street right now. The risk on environment of 2013 seems to have evaporated, with volatility heating up and many investors taking shelter in old stalwarts like consumer staples and even bond

Epilepsy device maker NeuroSigma sets terms for $50 million IPO
NeuroSigma, which develops electrical devices used to treat drug resistant epilepsy and depression, announced terms for its IPO on Monday. The Los Angeles, CA based company plans to raise $50 million by offering 3.6 million shares at a price

Epilepsy device maker NeuroSigma files for a $50 million IPO
NeuroSigma, which develops electrical devices used to treat drug resistant epilepsy and depression, filed on Tuesday with the SEC to raise up to $50 million in an initial public offering. The company is in pivotal trials to

22 US IPOs planned for the week of Jul 28
The following IPOs are expected to price this week Atara Biotherapeutics ( ATRA ), a early stage biotech targeting muscle loss in patients with end stage renal disease, plans to raise $75 million by offering 5.0

US IPO Recap: Biotech Sage and adtech TubeMogul pop over 60% on first day
On Tuesday, the chair of the Federal Reserve warned that valuations in biotech stocks were stretched, which sparked a selloff across the sector. On Friday, the week's only biotech IPO, Sage Therapeutics ( SAGE ), spiked 67%

Closing Update: U.S. Stocks Finish Higher For the Week, Shaking Off Geo-Political Tensions
Stocks rebounded Friday, erasing yesterday's steep sell off as tensions eased over the downing of a Maylasia Airlines jet and the start of a ground offensive in the Gaza Strip by Israeli forces. All 10 industry sectors in the

Sector Update: Health Care
Health care stocks were higher this afternoon with the NYSE Healthcare Sector Index 0.9% and shares of health care companies in the S&P 500 1.4% as a group. In company news, Shares of biopharmaceutical company Sage Therapeutics ( SAGE

Sector Update: Health Care Stocks Finishing On An Up Note; Sage Therapeutics Climbs Nearly 67% Post-IPO
Top Healthcare Stocks JNJ +1.35% PFE +0.23% ABT +1.50% MRK +1.08% AMGN +2.25% Healthcare stocks were higher this afternoon with the NYSE Healthcare Sector Index up 0.9% and shares of healthcare companies in the S&P 500 adding 1.4% as

Epilepsy biotech Marinus Pharmaceuticals sets terms for $52 million IPO
Marinus Pharmaceuticals, a clinical stage biotech developing an add on therapy for adults with epilepsy, announced terms for its IPO on Friday. The New Haven, CT based company plans to raise $52 million by offering 4.0 million

Sage Therapeutics increases proposed IPO deal size
Sage Therapeutics, which is developing treatments for life threatening epileptic seizures, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA based company now plans to raise $88 million by offering 5 million

Seizure biotech Sage Therapeutics sets terms for $60 million IPO
Sage Therapeutics, a biotech developing treatments for life threatening seizures, announced terms for its IPO on Tuesday. The Cambridge, MA based company plans to raise $60 million by offering 4.0 million shares at a price range of

India in talks to bring Iran gas via Arabian Sea
NEW DELHI (Commodity Online) : In an attempt to bypass the dangerous routes in Pakistan, India and Iran are discussing building a gas pipeline between the two countries along the bed of the Arabian Sea. According to South Asia Gas Enterprise Private Ltd ( SAGE ), "The carrying capacity of the